REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Bethelpharma Cia. Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Laboratorio Bethelpharma Cia. Ltda Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorio Bethelpharma Cia. Ltda is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on December 12, 2022. The total number of employees is currently 8 (2024). The latest financial highlights indicate a net sales revenue increase of 178.41% in 2025. Over the same period, its total assets grew by 106.21%. The enterprise’s net profit margin increased by 3.25% in 2025.

Headquarters
Calle C 16A N-E Jose Maria Roura, 14
Guayaquil; Guayas;

Contact Details: Purchase the Laboratorio Bethelpharma Cia. Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Bethelpharma Cia. Ltda report to view the information.
Registered Capital:
Purchase the Laboratorio Bethelpharma Cia. Ltda report to view the information.
Financial Auditors:
Purchase the Laboratorio Bethelpharma Cia. Ltda report to view the information.
Incorporation Date:
December 12, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Laboratorio Bethelpharma Cia. Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
178.41%
Total Operating Revenue
138.75%
Operating Profit
998.46%
EBITDA
789.96%
Net Profit/Loss for the Period
3327.68%
Total Assets
106.21%
Total Equity
68.43%
Operating Profit Margin
6.7%
Net Profit Margin
3.25%
Return on Equity (ROE)
-214.75%
Debt / Equity
-911.67%
Quick Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?